We kicked off 2 new searches on Friday.... - Industry - CMO, Boston based, #rarediseases, clinical stage, neuromuscular - Nonprofit - COO, East coast, #ALS, well funded, very visible, research focused Driving development and commercialization of therapies for those

Only 6 of the top 20 biopharma firms outperformed the market: and their edge was bold leadership. They chose diverse, cross-functional executives ready to rethink the rules. Are you set to build that kind of team? #Biotech #Leadership #Talent

Not so long ago, rare diseases were overlooked; now, they’re fueling the future of biopharma. Talent, innovation, and investment are converging like never before. This is a new era. #RareDisease #Biotech #LifeSciences #Leadership

Empathy, authenticity, lived experience: the new must-haves for biotech leaders. Rare disease advocacy is transforming the C-suite and shaping a future where patients lead the conversation. This is patient-first leadership. #RareDisease #Leadership #LifeSciences

The FDA Rare Disease Innovation Hub is actively breaking down silos: demanding adaptive, collaborative leaders. For execs, new strategies mean championing transparency and partnership across teams. Are your skills evolving with the sector? #RareDisease #Leadership

Patient advocates are now co-designing clinical trials: reshaping what leadership means in rare disease biotech. Authentic engagement, collaboration, and empathy are the new must-haves. This is how we build true innovation( together.) #RareDisease #PatientCentricity

Breakthroughs in rare disease aren't just transforming lives; they're reshaping the standards for leadership across biotech. Innovation, resilience, and empathy are now essential qualities for us all. #RareDisease #BiotechLeaders #Innovation

Patient advocates aren’t just “stakeholders”: they’re co-leaders in rare disease R&D. When the patient voice shapes studies, teams move faster and with greater trust. Leadership means listening. #RareDisease #ClinicalTrials

2026 is rare disease biotech’s “prove it” year. Winning leaders go beyond promise: delivering results with focus, urgency, discipline, and execution across teams. Building for approval + access? Let’s connect. #RareDisease #Biotech

Rare disease awareness is evolving; think art, music, AR. Clarity and creativity move hearts and build trust faster than any brochure. For leaders: stories and empathy are the new force multipliers. #RareDisease #Biotech #Healthcare

Rare disease breakthroughs go far beyond rare: unlocking platforms for oncology, neuro & immunology. Now’s the time for visionary leaders to translate edge-case science into industry-wide impact. #RareDisease #Biotech #Leadership

AI + digital fluency is now core for rare disease leaders: not just using tech, but shaping it: asking better data questions, setting trust, keeping patients at the center. The winning formula: science + systems + empathy. #RareDisease #AI #DigitalHealth #Biotech

Our potentially disease modifying therapy for myotonic dystrophy type 1, PGN-EDODM1, is being evaluated in the phase 2 FREEDOM2-DM1 clinical study. Learn more in the video below.

Biotech leaders are thinking global, not just local. 🌍 In the race for innovation, top talent can be anywhere: and the best are removing borders to build world-class teams. Where you work matters less than what you bring. #Biotech #Talent #Leadership

Kicking off our new Scientific Shorts series: a new series designed to break down big ideas in endocrinology. First up: What is the endocrine system? Watch Crinetics Chief Endocrinologist, Alan Krasner, M.D., explain how the endocrine system plays a critical role in everyday

Registration is now open for the ULF Scientific Symposium & Family Conference June 25-27 at Hilton Chicago/Oak Brook Hills Resort & Conference Center, Oak Brook, IL 60523. Take advantage of discounted early bird rates by registering by 3/13/26. Register bit.ly/4qUrYh0

The mission is pure: support women at each and every step in their career. While biotech does better than most industries as it relates to equality and diversity, any gap is too big. Please reach out to our team to learn more.

The mission is pure: support women at each and every step in their career. While biotech does better than most industries as it relates to equality and diversity, any gap is too big. Please reach out to our team to learn more.

Excellent insight as always.

Would you hire you ?? Tough conversations in full transparency: We are extremely fortunate to have the opportunity to work on very senior level high impact positions. We are hired to ensure that our client hires the best candidate possible. Since we are so proactive in our